🇺🇸 FDA

Company profile · Sponsor

Caribou

Caribou Biosciences

CRBU · NYSE biotech BERKELEY, CA, USA
Pipeline
4
Drugs
0
Patents
8

Quick answer

Caribou (CRBU) is a biotech company. headquartered in BERKELEY, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker CRBU
Exchange NYSE
Company type biotech
Headquarters BERKELEY, CA, USA
SEC CIK 0001619856

Pipeline (4)

Search pipeline →

  1. CB-010

    Caribou

    Lymphoma, Non-Hodgkin

    phase 1 gene therapy active

    1 trial

  2. CB-010

    Caribou

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  3. CB-011

    Caribou

    Relapsed/Refractory Multiple Myeloma

    phase 1 mab active

    1 trial

  4. CB-012

    Caribou

    Acute Myeloid Leukemia, in Relapse

    phase 1 small molecule terminated

    1 trial

Patents (8)

Search patents →

  1. US 11939604

    Modified cascade ribonucleoproteins and uses thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11932703

    Anti-ROR1 antibody and ROR1-targeting engineered cells

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11472884

    Humanized BCMA antibody and BCMA-CAR-T cells

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11312953

    Compositions and methods of nucleic acid-targeting nucleic acids

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11299549

    Humanized BCMA antibody and BCMA-CAR-T cells

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11142583

    BCMA-CAR-natural killer (NK) cells and methods related thereto

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11021542

    Humanized BCMA antibody and BCMA-CAR-T cells

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10954498

    Modified cascade ribonucleoproteins and uses thereof

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Caribou?

Caribou (CRBU) is a biotech company. headquartered in BERKELEY, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Caribou sponsor?

We track 4 ClinicalTrials.gov-linked programs for Caribou, including CB-010 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Caribou company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.